Our QA team is debating whether to use bulk import tools for migrating 1,200 historical nonconformance records from our previous system or to manually re-enter critical cases. The concern centers on audit trail integrity and regulatory inspection readiness.
With manual entry, we get complete audit logs showing who entered what and when, but it’s resource-intensive (estimated 120 hours). Bulk import is faster but I’m worried about metadata mapping accuracy and whether the audit trail will satisfy FDA inspectors who want to trace data lineage. Has anyone gone through a regulatory inspection after doing bulk nonconformance imports? What questions did inspectors ask about the imported data’s integrity?
The audit log completeness issue is real. Bulk imports create a single audit entry per record showing the import action, but you lose the granular field-level history that manual entry provides. For regulatory inspection readiness, I recommend a hybrid approach: bulk import the core data, but preserve original timestamps, user IDs, and status changes in custom audit fields. Map your legacy system’s audit trail to custom fields like original_created_by__c, original_modified_date__c, and legacy_status_history__c. This gives inspectors the data lineage they need.
Metadata mapping is where most bulk imports fail data integrity checks. Nonconformance records have complex relationships - linked CAPAs, affected products, responsible parties, root cause classifications. I’ve seen imports where these relationships broke because the mapping used legacy IDs instead of Vault object IDs. Your import tool needs to resolve all these references first. Run a reconciliation report comparing record counts, status distributions, and relationship links between source and target. If discrepancies exist, inspectors will find them.
We did bulk import of 2,800 NC records last year before our ISO audit. Inspectors specifically asked for: 1) Documentation of the import process including validation steps, 2) Proof that imported data matched source system exports, 3) Evidence that business rules and workflows were applied correctly. The audit trail showed the import user and timestamp, which was acceptable as long as we maintained the original creation metadata in custom fields.
That’s helpful context. Our legacy system does track detailed status transitions and approvals. If we map those to custom audit fields as suggested, would that satisfy the 21 CFR Part 11 requirements for audit trails? Or does the FDA specifically require that audit data be in Vault’s native audit log structure?